Related content

MAGE-1/Heat shock protein 70/MAGE-3 fusion protein vaccine in nanoemulsion enhances cellular and humoral immune responses to MAGE-1 or MAGE-3 in vivo

By Ge Wei   Sui Yan-Fang   Wu Dao-Cheng   Sun Yu-Jing   Chen Guang-Sheng   Li Zeng-Shan   Si Shao-Yan   Hu Pei-Zhen   Huang Yang   Zhang Xiu-Min  

Cancer Immunology, Immunotherapy, Vol. 55, Iss. 7, 2006-07 ,pp. : 841-849

Springer Publishing Company

Access to resources Recommend Favorite

The antitumor immune responses induced by nanoemulsion-encapsulated MAGE1-HSP70/SEA complex protein vaccine following peroral administration route

By Ge Wei  

Cancer Immunology, Immunotherapy, Vol. 58, Iss. 2, 2009-02 ,pp. : 201-208

Springer Publishing Company

Access to resources Recommend Favorite

In vivo responses to vaccination with Mage-b, GM-CSF and thioglycollate in a highly metastatic mouse breast tumor model, 4T1

By Gravekamp Claudia   Leal Belinda   Denny Ashley   Bahar Rumana   Lampkin Shellye   Castro Francisco   Kim Sun   Moore Dan   Reddick Robert  

Cancer Immunology, Immunotherapy, Vol. 57, Iss. 7, 2008-07 ,pp. : 1067-1077

Springer Publishing Company

Access to resources Recommend Favorite

Evaluation of MAGE A1 in oral squamous cell carcinoma

By            

Oncology Reports, Vol. 27, Iss. 6, 2012-01 ,pp. : 1843-1848

Spandidos Publications

Access to resources Recommend Favorite

Frequent expression of MAGE1 tumor antigens in bronchial epithelium of smokers without lung cancer

By                    

Experimental and Therapeutic Medicine, Vol. 2, Iss. 1, 2011-01 ,pp. : 137-142

Spandidos Publications

Access to resources Recommend Favorite